Clostridium
Optimer Pharmaceuticals Sponsors ECCMID/ICC Symposium on Clostridium Difficile-Associated Disease (CDAD)
Published in Hospital Business Week, April 8th, 2007
Optimer Pharmaceuticals, Inc. (Nasdaq:OPTR) announced that the company will sponsor a symposium focused on the diagnostic and treatment challenges of Clostridium difficile-associated disease (CDAD), a severe form of hospital-acquired diarrhea, which in the most serious cases can cause death. The symposium will be held on March 31, 2007 at the 17th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) in Munich, Germany.
CDAD, the most common form of hospital-acquired diarrhea, affects more than 500,000 people in the United States(1) and one out of every 1,000 patients hospitalized in Europe(2). Increased incidence and severity of CDAD, coupled with...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Business Week
More Articles from Hospital Business Week
- Albert Einstein Healthcare Network
Einstein Philadelphia Pioneers Use of Technology to Ease Stress of Medical Emergencies - Alzheimer Disease
Avid Announces Results of AV-1 Molecular Imaging Agent for Alzheimer's Disease Presented at AD/PD Meeting - Alzheimer Disease
Secured Independence, Inc. Launches Program to Reduce Disability and Claims Costs for LTC Insurance Policyholders - American Type Culture Collection (ATCC)
ATCC Proficiency Standard Program Enlists American Proficiency Institute - Amerinet Inc.
Diagnostix Releases Software Enhancements - Creates Powerful Pharmacy Supply Spend Tool - AmeriPath
Ameripath, Inc. Announces 2006 Fourth Quarter And Full Year Financial Results - More from this issue of Hospital Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
